Gabon vs Mozambique: Cause of death, by non-communicable diseases, ages 60+
Gabon
53.7%
in 2021
Mozambique
54.1%
in 2021
Gabon rank
172nd
Mozambique rank
171st
Cause of death, by non-communicable diseases, ages 60+ over time
- Gabon
- Mozambique
How they compare
Mozambique currently reports 54.1% against 53.7% in Gabon, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Gabon ahead.
Gabon ranks 172nd and Mozambique ranks 171st of 185 countries.
Across the 3 decades both report, Gabon averaged higher in 2 and Mozambique in 1.
Head to head by decade
| Decade | Gabon | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.0% | 50.5% | 12.4% | Gabon |
| 2010s | 69.7% | 63.2% | 6.5% | Gabon |
| 2020s | 55.3% | 60.3% | 4.9% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Gabon or Mozambique?
- Mozambique, at 54.1% against 53.7% in Gabon as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Gabon and Mozambique?
- 0.4%, with Mozambique ahead.
- How many years of comparable data are there for Gabon and Mozambique?
- 6 years are reported by both, from 2000 to 2021.
- How do Gabon and Mozambique rank globally for cause of death, by non-communicable diseases, ages 60+?
- Gabon ranks 172nd and Mozambique ranks 171st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.